TACARYL Drug Patent Profile
✉ Email this page to a colleague
When do Tacaryl patents expire, and when can generic versions of Tacaryl launch?
Tacaryl is a drug marketed by Westwood Squibb and is included in one NDA.
The generic ingredient in TACARYL is methdilazine. There are four drug master file entries for this compound. Additional details are available on the methdilazine profile page.
Summary for TACARYL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 22 |
Patent Applications: | 2,588 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TACARYL at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TACARYL
US Patents and Regulatory Information for TACARYL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Westwood Squibb | TACARYL | methdilazine hydrochloride | SYRUP;ORAL | 011950-007 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Westwood Squibb | TACARYL | methdilazine | TABLET, CHEWABLE;ORAL | 011950-009 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Westwood Squibb | TACARYL | methdilazine hydrochloride | TABLET;ORAL | 011950-006 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |